Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470202 | SCV000549647 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2020-06-06 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 2711 of the BRCA2 protein (p.Ala2711Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. In summary, this variant is a novel missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a BRCA2-related disease. |
Color Diagnostics, |
RCV000776389 | SCV000911849 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-01 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800679 | SCV002047227 | uncertain significance | not provided | 2021-06-06 | criteria provided, single submitter | clinical testing |